TVGN Tevogen Bio Holdings Inc.companySEC Filings & Insider Trading Activity 2026
Latest Tevogen Bio Holdings Inc. (TVGN) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 31, 2026, a 10-Q quarterly report filed on May 15, 2026, an 8-K current report filed on July 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Tevogen Bio Holdings Inc. (TVGN) (SEC CIK 1860871), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Tevogen Bio Holdings Inc.
Ask AI about TVGN filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting TVGN positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on TVGN.
Annual Reports Archive10-K
AI-powered analysis of Tevogen Bio Holdings Inc. (TVGN) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Tevogen Bio Holdings Inc. (TVGN) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Tevogen Bio Holdings Inc. (TVGN) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Profitability | |||
| Operating Income | -$8.8M | -$53.6M | -$26.1M |
| Net Income | -$67K | -$13.7M | -$26.3M |
| Balance Sheet | |||
| Total Assets | $17.0M | $3.5M | $4.4M |
| Equity | -$17.4M | -$6.7M | -$8.2M |
| ROE | 0.4% | 205.7% | 319.1% |
| Per Share | |||
| EPS | $-2.44 | $-0.07 | $-8.08 |
| Cash Flow | |||
| Operating CF | -$1.4M | -$12.0M | -$12.3M |
| CapEx | $133K | - | $64K |
Source: XBRL financial data from Tevogen Bio Holdings Inc. (TVGN) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 30, 2026 | - | - | - |
10-Q | May 15, 2026 | Mar 31, 2026 | - | |
8-K | Apr 22, 2026 | - | - | - |
10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
8-K | Mar 25, 2026 | - | - | - |
8-K | Mar 4, 2026 | - | Analysis | - |
8-K | Feb 25, 2026 | - | Analysis | - |
8-K | Jan 30, 2026 | - | - | |
10-Q | Nov 14, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 14, 2025 | Jun 30, 2025 | - | |
10-Q | May 14, 2025 | Mar 31, 2025 | - | |
10-K | Apr 2, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Nov 19, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 14, 2024 | Jun 30, 2024 | - | |
10-Q | May 28, 2024 | Mar 31, 2024 | - | |
10-K | Apr 29, 2024 | Dec 31, 2023 | - | |
SC 13G | Mar 4, 2024 | - | - | |
SC 13D | Feb 22, 2024 | - | - | |
SC 13D | Feb 22, 2024 | - | - | |
SC 13G | Feb 14, 2024 | - | - | |
SC 13G | Feb 14, 2024 | - | - | |
SC 13G | Jan 22, 2024 | - | - | |
10-Q | Nov 13, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 21, 2023 | Jun 30, 2023 | - | |
SC 13G | Jul 27, 2023 | - | - |
13F Fund Holdings: Quarterly Trend
Latest: Q4 2025Aggregate TVGN share value held by 13F filers tracked by SignalX, by quarter.
- Goldman Sachs Group+152.6K (+126%)
- Morgan Stanley+123.6K (+98%)
- Vanguard Group Inc+44.7K (+4%)
- Wells Fargo & Co+25.1K (+124%)
- State Street Corp+17.7K (+15%)
- BlackRock357.4K (-23%)
- BNY Mellon23.6K (-42%)
- AQR Capital Management9.8K (-43%)
- Invesco Ltd6.3K (-35%)
- FMR LLC (Fidelity)4.1K (-4%)
- Citadel Advisors LLC+17.2K
- Prudential Financial+11.5K
- StoneX Group Inc.+10.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 75 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest TVGN SEC filings in 2026?
Tevogen Bio Holdings Inc. (TVGN) has filed a 10-K annual report on March 31, 2026, a 10-Q quarterly report on May 15, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did TVGN file its most recent 10-K annual report?
Tevogen Bio Holdings Inc. (TVGN) filed its most recent 10-K annual report on March 31, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view TVGN 10-Q quarterly reports?
Tevogen Bio Holdings Inc. (TVGN)'s most recent 10-Q quarterly report was filed on May 15, 2026. SignalX displays every TVGN 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has TVGN filed recently?
Tevogen Bio Holdings Inc. (TVGN)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find TVGN insider trading activity (Form 4)?
SignalX aggregates every TVGN Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does TVGN file with the SEC?
Tevogen Bio Holdings Inc. (TVGN) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TVGN filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Tevogen Bio Holdings Inc. (TVGN).
What is TVGN's SEC CIK number?
Tevogen Bio Holdings Inc. (TVGN)'s SEC CIK (Central Index Key) number is 1860871. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1860871 to look up all TVGN filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find TVGN return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Tevogen Bio Holdings Inc. (TVGN) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Tevogen Bio Holdings Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 38+ filings.